Membrane permeabilization by oligomeric α-synuclein: In search of the mechanism

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  van Rooijen, Bart D ^a   Claessens, Mireille M A E ^a   Subramaniam, Vinod ^a,b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; DEXTRAN; DYE; LIPID; OLIGOMER; 1 PALMITOYL 2 OLEOYLGLYCERO 3 PHOSPHOGLYCEROL; 1-PALMITOYL-2-OLEOYLGLYCERO-3-PHOSPHOGLYCEROL; AMYLOID; PHOSPHATIDYLGLYCEROL; PROTEIN;

ADSORPTION; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MEMBRANE TRANSPORT; CELL STRUCTURE; CELL VACUOLE; IN VITRO STUDY; LIPID BILAYER; MEMBRANE STABILIZATION; MEMBRANE STRUCTURE; PROTEIN LIPID INTERACTION; CELL MEMBRANE; CHEMISTRY; CONFOCAL MICROSCOPY; HUMAN; METABOLISM; METHODOLOGY; NERVE CELL; PERMEABILITY;

ADSORPTION; ALPHA-SYNUCLEIN; AMYLOID; CELL MEMBRANE; DEXTRANS; HUMANS; LIPID BILAYERS; LIPIDS; MICROSCOPY, CONFOCAL; NEURONS; PERMEABILITY; PHOSPHATIDYLGLYCEROLS; PROTEINS;

EID: 78650763561     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014292     Document Type: Article

References (37)

1. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, et al. (1997) Alpha-synuclein in Lewy bodies. Nature 388: 839-840.
2. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, et al. (2004) Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 364: 1167-1169.
3. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
4. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
5. Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, et al. (2003) alpha-Synuclein locus triplication causes Parkinson's disease. Science 302: 841.
6. Zarranz JJ, Alegre J, Gómez-Esteban JC, Lezcano E, Ros R, et al. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55: 164-173.
7. Lashuel HA, Lansbury PT (2006) Are amyloid diseases caused by protein aggregates that mimic bacterial pore-forming toxins? Quarterly Reviews Of Biophysics 39: 167-201.
8. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, et al. (2007) Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 27: 9220-9232.
9. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300: 486-489.
10. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, et al. (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279: 46363-46366.
11. Lashuel HA, Hartley D, Petre BM, Walz T, Lansbury PT, Jr. (2002) Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418: 291.
12. Volles MJ, Lee SJ, Rochet JC, Shtilerman MD, Ding TT, et al. (2001) Vesicle permeabilization by protofibrillar alpha-synuclein: implications for the pathogenesis and treatment of Parkinson's disease. Biochemistry 40: 7812-7819.
13. Zhu M, Li J, Fink AL (2003) The association of alpha-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Biol Chem 278: 40186-40197.
14. van Rooijen BD, Claessens MMAE, Subramaniam V (2008) Membrane binding of oligomeric alpha-synuclein depends on bilayer charge and packing. Febs Letters 582: 3788-3792.
15. van Rooijen BD, Claessens MMAE, Subramaniam V (2009) Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core. Biochimica Et Biophysica Acta-Biomembranes 1788: 1271-1278.
16. Volles MJ, Lansbury PT, Jr. (2002) Vesicle permeabilization by protofibrillar alpha-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism. Biochemistry 41: 4595-4602.
17. Quist A, Doudevski I, Lin H, Azimova R, Ng D, et al. (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102: 10427-10432.
18. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, et al. (2002) Alphasynuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322: 1089-1102.
19. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell nonselective membrane-lytic peptides. Biochimica Et Biophysica Acta-Biomembranes 1462: 55-70.
20. Montal M, Mueller P (1972) Formation of bimolecular membranes from lipid monolayers and a study of their electrical properties. Proc Natl Acad Sci U S A 69: 3561-3566.
21. Qin F (2004) Restoration of single-channel currents using the segmental k-means method based on hidden Markov modeling. Biophys J 86: 1488-1501.
22. Ladokhin AS, Wimley WC, White SH (1995) Leakage of membrane vesicle contents: Determination of mechanism using fluorescence requenching. Biophysical Journal 69: 1964-1971.
23. Kim HY, Cho MK, Kumar A, Maier E, Siebenhaar C, et al. (2009) Structural Properties of Pore-Forming Oligomers of alpha-Synuclein. J Am Chem Soc.
24. Kostka M, Hogen T, Danzer KM, Levin J, Habeck M, et al. (2008) Single particle characterization of iron-induced pore-forming alpha-synuclein oligomers. Journal Of Biological Chemistry 283: 10992-11003.
25. van Rooijen BD, van Leijenhorst-Groener KA, Claessens MMAE, Subramaniam V (2009) Tryptophan fluorescence reveals structural features of alpha-synuclein oligomers. J Mol Biol 394: 826-833.
26. Valincius G, Heinrich F, Budvytyte R, Vanderah DJ, McGillivray DJ, et al. (2008) Soluble Amyloid beta-Oligomers Affect Dielectric Membrane Properties by Bilayer Insertion and Domain Formation: Implications for Cell Toxicity. Biophysical Journal 95: 4845-4861.
27. Capone R, Quiroz FG, Prangkio P, Saluja I, Sauer AM, et al. (2009) Amyloidbeta-Induced Ion Flux in Artificial Lipid Bilayers and Neuronal Cells: Resolving a Controversy. Neurotoxicity Research 16: 1-13.
28. Rubas W, Jezyk N, Grass GM (1995) Mechanism of dextran transport across rabbit intestinal tissue and a human colon cell-line (CACO-2). J Drug Target 3: 15-21.
29. Shoemaker SD, Vanderlick TK (2002) Intramembrane electrostatic interactions destabilize lipid vesicles. Biophysical Journal 83: 2007-2014.
30. Nuscher B, Kamp F, Mehnert T, Odoy S, Haass C, et al. (2004) alpha-synuclein has a high affinity for packing defects in a bilayer membrane-A thermodynamics study. Journal Of Biological Chemistry 279: 21966-21975.
31. Tamamizu-Kato S, Kosaraju MG, Kato H, Raussens V, Ruysschaert JM, et al. (2006) Calcium-triggered membrane interaction of the alpha-synuclein acidic tail. Biochemistry 45: 10947-10956.
32. Hauser H, Shipley GG (1984) Interactions Of Divalent-Cations With Phosphatidylserine Bilayer-Membranes. Biochemistry 23: 34-41.
33. Melikov KC, Frolov VA, Shcherbakov A, Samsonov AV, Chizmadzhev YA, et al. (2001) Voltage-induced nonconductive pre-pores and metastable single pores in unmodified planar lipid bilayer. Biophysical Journal 80: 1829-1836.
34. Tsigelny IF, Bar-On P, Sharikov Y, Crews L, Hashimoto M, et al. (2007) Dynamics of alpha-synuclein aggregation and inhibition of pore-like oligomer development by beta-synuclein. FEBS J 274: 1862-1877.
35. Lee HJ, Choi C, Lee SJ (2002) Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form. J Biol Chem 277: 671-678.
36. Zakharov SD, Hulleman JD, Dutseva EA, Antonenko YN, Rochet JC, et al. (2007) Helical alpha-synuclein forms highly conductive ion channels. Biochemistry 46: 14369-14379.
37. Chen PS, Toribara TY, Warner H (1956) Microdetermination of Phosphorus. Anal Chem 28: 1756-1758.